Wei Li

5PUBLICATIONS
6CO-AUTHORS
Medical infection agents (incl. prions)Epidemiological modellingInfant and child healthMedical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Apr 13, 2026
Fixed-Dose Rifapentine-Isoniazid (1HP) for Tuberculosis Preventive Treatment in Chinese Adults: A Prospective Real-World Safety and Pharmacokinetic Study.

Senlin Zhan, Weijian Liu, Liangzi Yang

|Jul 21, 2025
Safety, Feasibility, and Rifapentine Plasma Concentration in Chinese Children With 1 Month of Daily Rifapentine Plus Isoniazid for Tuberculosis Infection.

Weijian Liu, Tian He, Senlin Zhan

|Nov 18, 2024
Clinical Pharmacist Involved in the Treatment of <i>Pneumocystis carinii</i> Pneumonia: A Case Report.

Fangyuan Lai, Xiuqiong Huang, Jiao Peng

|May 31, 2022
Linezolid-Associated Neuropathy in Patients with MDR/XDR Tuberculosis in Shenzhen, China.

Peize Zhang, Wei Li, Miaona Liu

Pageof 1